Tanshinone IIA exhibits anticonvulsant activity in zebrafish and mouse seizure models by Buenafe, O. E. et al.
Tanshinone IIA Exhibits Anticonvulsant Activity in Zebrafish and
Mouse Seizure Models
Olivia Erin Buenafe,† Adriana Orellana-Paucar,†,‡ Jan Maes,† Hao Huang,§ Xuhui Ying,¶,○
Wim De Borggraeve,⊥ Alexander D. Crawford,†,∥ Walter Luyten,▽ Camila V. Esguerra,*,†
and Peter de Witte*,†
†Laboratory for Molecular Biodiscovery, Department of Pharmaceutical & Pharmacological Sciences, KU Leuven - University of
Leuven, 3000 Leuven, Belgium
‡Facultad de Ciencias Quimicas, Escuela de Bioquimica y Farmacia, Universidad de Cuenca, Cuenca 101168, Ecuador
§College of Pharmacy, Gannan Medical University, Ganzhou 341000, China
¶College of Pharmacy, Nankai University, Tianjin 300071, China
○Analysis Center, Tsinghua University, Beijing 100084, China
⊥Molecular Design and Synthesis, Department of Chemistry, KU Leuven - University of Leuven, 3001 Leuven, Belgium
∥Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 4362 Esch-sur-Alzette, Luxembourg
▽Department of Biology, KU Leuven - University of Leuven, 3000 Leuven, Belgium
ABSTRACT: Danshen or Chinese red sage (Salvia miltiorrhiza,
Bunge) is used by traditional Chinese medicine (TCM)
practitioners to treat neurological, cardiovascular, and cerebrovas-
cular disorders and is included in some TCM formulations to
control epileptic seizures. In this study, acetonic crude extracts of
danshen inhibited pentylenetetrazol (PTZ)-induced seizure activity
in zebrafish larvae. Subsequent zebrafish bioassay-guided fractio-
nation of the extract resulted in the isolation of four major
tanshinones, which suppressed PTZ-induced activity to varying
degrees. One of the active tanshinones, tanshinone IIA, also
reduced c-fos expression in the brains of PTZ-exposed zebrafish
larvae. In rodent seizure models, tanshinone IIA showed anticonvulsive activity in the mouse 6-Hz psychomotor seizure test in a
biphasic manner and modified seizure thresholds in a complex manner for the mouse i.v. PTZ seizure assay. Interestingly,
tanshinone IIA is used as a prescription drug in China to address cerebral ischemia in patients. Here, we provide the first in vivo
evidence demonstrating that tanshinone IIA has anticonvulsant properties as well.
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Epilepsy affects approximately 60 million people worldwide,of whom 30% suffer from pharmacoresistant seizures. The
economics of maintaining a cost-effective therapeutic regimen
hinge on its long-term efficacy and the probability of patients
developing treatment-resistant seizures or possible side-effects
ranging from sedation to Steven−Johnson syndrome.1 To
address such issues, there is an ongoing hunt for new
antiepileptic drugs (AEDs) with novel mechanisms of action
and with minimal or no side-effects.
There is a resurgence of interest in exploring plant, microbial,
and marine resources used in traditional medicine for potential
drug leads. According to the World Health Organization
(WHO), 70−80% of the population in developing and
developed countries have used, or depend on such therapies,
which became the impetus for efforts in bioprospecting and
drug development.2 Despite prevalent skepticism, as many as
25% of pharmaceutical drugs on the market are plant-based and
were discovered through investigations on traditional or folk
medicine practiced by different cultures.1,2 The rationale behind
this approach in drug discovery is that small molecules isolated
or derived from natural sources offer a more diverse set of
structures compared with compounds synthesized through
medicinal chemistry or combinatorial techniques.2
Each plant or marine extract can be treated as a library
potential of hits, which can be screened using an appropriate
medium- to high-throughput in vivo model such as zebrafish
(Danio rerio), a freshwater teleost of the Cyprinidae family.3,4 In
screening for potential hits and leads for AED development, we
have previously described the use of larval zebrafish as a
platform for pinpointing AED-like activity of small molecules
isolated from plant sources.3,4 In a study conducted by Baraban
et al., 7-days post-fertilization (dpf) zebrafish larvae display
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seizure-like behavior (e.g., “whirlpool” swimming, loss of
posture) upon exposure to the chemoconvulsant pentylenete-
trazol (PTZ).5,6 This response to PTZ is comparable to rodent
models, with similar outcomes to treatment with known
antiepileptic drugs.6−8 This similarity, as well as other factors
such as ease of propagation and sample introduction and the
availability of automated scoring or tracking devices, positions
zebrafish as a robust model for prescreening extracts (and
eventually isolated compounds) from various plant libraries or
ethnopharmacopeias, such as the materia medica of traditional
Chinese medicine (TCM). From a random sampling of 40
plants from the aforementioned materia medica used by TCM
practitioners to treat various conditions, including epilepsy, we
selected Chinese red sage or danshen.
Danshen (Salvia miltiorrhiza, Bunge) is a plant from TCM’s
materia medica that is often used in cardio- and cerebrovascular
disorders.9,10 It is commonly prescribed by TCM practitioners
to stroke patients and is included in a TCM drug formulation
ding xian wan to control epileptic seizures.9,11 The active
compounds documented in danshen belong mostly to a specific
diterpenoid class referred to as tanshinones and salvianolic acid
derivatives. The former are isolated mainly via lipophilic
extraction of the dried root powder and are also responsible for
the characteristic red color of the herb (danshen literally means
“red root”). Danshen’s predominant bioactive constituent,
tanshinone IIA, has been a focus of research for the past
decade in the field of cardiovascular and cerebral ischemia. The
reported biological activities of tanshinone IIA vary from
antiatherosclerotic12,13 to cardioprotective9,13 and neuropro-
tective.14,15 Because of the extensive preclinical and clinical
studies on its cardioprotective and antiatherosclerotic proper-
ties, tanshinone IIA and its more water-soluble derivative
sodium tanshinone IIA sulfonate are used in China as
prescription treatments for angina pectoris and stroke.13,15
The neuroprotective effects of danshen extracts on cerebral
ischemia and Alzheimer’s disease models have been elucidated,
but scant data are available for its ascribed anticonvulsive
effects, making it a potential library of small molecules to be
screened in larval zebrafish for antiepileptic activity.
! RESULTS AND DISCUSSION
Crude Extract of Danshen and Its Active Components
Reduce PTZ-Induced Movement in 7-dpf Larval Zebra-
fish. Two different exposure times to the crude extract were
initially tested in order to determine the incubation period
required for optimal activity in zebrafish larvae. Previous
empirical data obtained for other crude extracts and
compounds tested revealed that shorter exposure times were
often sufficient to detect bioactivity, whereas for some
compounds a longer overnight incubation was necessary 4
(data not shown). Zebrafish larvae were exposed to different
concentrations of the acetone crude extract of danshen for 1 h
(for 7-dpf larvae) or 18 h (for 6-dpf larvae) before PTZ
treatment and activity tracking. Danshen crude extract reduced
PTZ-induced activity in larvae after 1-h exposure time at its
maximum tolerated concentration (MTC, 5 μg/mL), but not
after 18 h of exposure (Figure 1). Beyond the MTC, larvae
displayed bradycardia, loss of posture, and delayed touch
response after 3 h of exposure, followed by death after 18 h.
The crude extract of danshen was subjected to analytical
HPLC analysis, which revealed the presence of 11 peaks
(Figure 2). In order to differentiate the peaks in terms of their
intrinsic activity aside from approximate abundance, these were
initially dissolved in equivolume amounts (10 μL) of DMSO
before exposing 7-dpf larvae in 0.3! Danieau’s solution (1%
final DMSO concentration) for 18 h before subsequent
exposure to PTZ; peaks that showed signs of toxicity in larvae
after the pre-exposure period were titered from half to one-
tenth of their original unknown concentrations. Four peaks
were found to be active in this manner (data not shown) and
became the focus of semipreparative isolation for structure
elucidation via NMR spectroscopy. One- and two-dimensional
NMR analyses of the isolated peaks showed that they are
structurally related to each other as tanshinones (Table 1), with
the chemical shifts matching those listed in the literature.16
Active peaks were identified as 15,16-dihydrotanshinone I (1),
cryptotanshinone (2), tanshinone IIA (3), and miltirone (4)
(Figure 3), with average yields of 2.8% for miltirone to 13.1%
for cryptotanshinone (Table 1).
Concentration−response curves were obtained for the active
tanshinones. The MTC values for 1, 2, 3, and 4 were 2.5, 17,
>80 (at maximum solubility), and 7 μM, respectively, with
greatest reduction in PTZ-induced activity in 7-dpf larvae at
these concentrations (Figure 4A−D). 15,16-Dihydrotanshinone
I (1) at its active concentration, however, did not display
consistent reduction of PTZ-induced activity over the course of
30 min compared with the other tanshinones (Figure 4A).
Cryptotanshinone (2) displayed significant reduction of PTZ-
related activity only at its MTC (Figure 4B), unlike miltirone
(4) whose effective concentration was lower than its MTC
(Figure 4D). Tanshinone IIA (3), at 80 μM, also displayed
significant reduction of PTZ-induced activity throughout the
duration of the assay (Figure 4C).
Taking into account the estimated percent content of these
active tanshinones in the crude extract, the crude extract (at 5
μg/mL, see Figure 1) shows equivalent reduction of PTZ-
Figure 1. PTZ-induced activity curve of 7-dpf zebrafish larvae after
pretreatment with different concentrations of danshen crude extract.
Results were normalized against PTZ controls (set at 100%). Exposure
to extract during 1 h (A) or 18 h (B). Analysis was done by two-way
ANOVA, with P values <0.05 (∗), <0.01 (∗∗), and <0.001 (∗∗∗)
indicated per time period.
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induced activity in larvae at 3−60-fold lower concentrations of
total tanshinones compared with individual tanshinones (Figure
4, Table 1). This indicates that there may be a complex
interplay of the compounds present in the extract, which act in
a synergistic manner, wherein the activity of the whole (or
crude) extract is greater than the sum of its active parts.17 The
complexity of this aforementioned interplay within the larva
may contribute to the loss of activity upon 18 h of pre-exposure
prior to treatment with PTZ. Other less-active or inactive
tanshinones may also play a role in either improving the
compounds’ penetration into the fish’s system by modulating
the drug-efflux pumps present in cells18,19 in a similar fashion to
those in bacteria20 and cancer cells21 or by modifying the
solubilities of the active compounds.17
Because the lipophilic fraction of danshen has not been fully
explored for its potential anticonvulsant effects in earlier
literature, the identified active tanshinones bear further analysis,
along the lines of structure−activity relationships. In a study
conducted by Lee et al., tanshinones isolated from danshen
displayed different in vitro affinities to the central γ-amino-
butyric acid receptor (GABAA receptor).
22 A danshen
diterpenoid, miltirone, was reported to have a sedative activity
and was shown in vitro to be a partial GABAA receptor
agonist.22 Tanshinone IIA was also shown to have affinity for
the same receptor as miltirone but is approximately 10 times
weaker.22 The results of the in vivo larval PTZ assay we
performed show this disparity of activity between miltirone and
tanshinone IIA, with significant reduction of PTZ-activity at
6.125 and 80 μM, respectively (Figure 4). According to Lee et
al., the activity of tanshinones in modulating benzodiazepine
receptors is due to the presence of the A ring regardless of the
addition of methyl moieties at position 4 (Figure 3), and the
replacement of the furan ring D with an isopropyl group.23 Our
results also imply that the activity of the compounds can differ
from each other based on the modifications on the A ring and
the furan D ring (Figure 3). We observed that the modification
of ring D via hydrogenation at Δ15,16 resulted in a 5-fold
increase in activity between cryptotanshinone and tanshinone
IIA.
Among the four tanshinones that were active in our larval
PTZ assays, tanshinone IIA and miltirone possess significant
characteristics that need to be considered. Miltirone appears
more active than tanshinone IIA. However, its narrow effective-
concentration range (Figure 4D) and its sedative activity22 as a
potential side effect make the compound less attractive for
further development. As noted earlier,10,13,24 tanshinone IIA
has been identified as a predominant bioactive constituent of
danshen and developed as a prescription drug for cardio- and
cerebrovascular disorders. We therefore chose to focus on this
specific compound for additional experiments.
Intravenous Microinjection of Tanshinone IIA in
Zebrafish Larvae. Tanshinone IIA is poorly soluble in
water; hence its indicated MTC value is beyond its maximum
solubility at 80 μM. In order to observe the compound’s further
reduction of PTZ-induced movement in larvae as well as to be
able to approximate the dosage in milligrams per kilogram,
additional locomotor recordings were made on intravenously
(i.v.)-injected 3-dpf zebrafish larvae with either vehicle (1:1
DMSO/0.3! Danieau’s solution) or 100 mM tanshinone IIA
solutions. Intravenously injected tanshinone IIA significantly
reduced PTZ-induced movement in 3-dpf larvae (Figure 5).
Taking into account the bolus volume (0.5 nL), concentration
(100 mM), and average weight of a 3-dpf larva (0.25 mg), the
estimated calculated dose was 59 mg/kg larva.
The results from intravenous administration of tanshinone
IIA into larvae were comparable to those generated from pre-
exposure to the compound in larval medium. Regardless of
larval stage or mode of administration, both techniques resulted
in a statistically significant 50% reduction of PTZ-induced
movement, indicating that the solubility of tanshinone IIA
alone cannot fully account for the 50% reduction limit.
Reduction of Brain c-fos Expression in Zebrafish
Larvae Treated with Tanshinone IIA. Previous studies
have shown the robustness of the in situ hybridization assay for
c-fos transcription in the zebrafish larval CNS as a high-
throughput indicator of the neural response to chemo-
convulsant treatment in lieu of electroencephalographic
Figure 2. Reverse-phase HPLC chromatograms of danshen crude
extract (CE) using the (A) analytical and (B) semipreparative
columns. The calculated percentage yields from semipreparative
HPLC are listed in Table 1.
Table 1. Fractions Isolated Using Semipreparative Reverse-
Phase HPLC Analysis of Danshen Crude Acetone Extract
Residue (130.6 mg), with Yields Expressed As Percentage












in 5 μg/mL CE
(μM) peak identity (via NMR)
1 6.13 4.7 0.84 15,16-dihydrotanshinone I
2 17.07 13.1 2.2 cryptotanshinone
3 10.12 7.7 1.3 tanshinone IIA
4 3.68 2.8 0.50 miltirone
aCE, crude extract.
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(EEG) recordings.25 Confirmation of neuroprotective activity
of tanshinone IIA was initially carried out through whole mount
in situ hybridization (WISH) of 6/7-dpf larvae that were pre-
exposed to the test compounds for 18 h before subsequent
exposure to PTZ. Overexpression of the oncogene c-fos in the
brain was scored for sham-, vehicle-, and compound-treated
larvae, because the extent of c-fos overexpression has been
linked to severity of seizures and neuronal insults in the
brain.6,25 Larvae exposed to tanshinone IIA (80 μM) for 18 h
before PTZ treatment showed a reduction of c-fos expression
(Figure 6) compared with larvae pre-exposed to vehicle, with
significant reduction of staining in the hindbrain. Quantitative
analysis confirms the reduction of c-fos staining in the brain by
as much as one-third (Figure 7). Subsequent c-fos WISH
analysis was also performed on 3-dpf larvae i.v.-injected with
either vehicle or 100 mM tanshinone IIA before PTZ
treatment. Results show a 50% reduction of c-fos expression
in tanshinone IIA-injected larvae that were exposed to PTZ
(Figure 8). This reduction of c-fos expression corresponds to
the reduction of PTZ-induced movement in the larval
behavioral assays (Figures 4C and 5).
Regardless of mode of administration, tanshinone IIA
demonstrates significant reduction of c-fos expression, indicat-
ing the potential anticonvulsant action of the compound, since
an increase in brain c-fos gene expression is a well-documented
marker for seizure induction and brain damage.6,25 The
reduction of c-fos expression by tanshinone IIA also implies
that the compound is able to penetrate into the brain to a
certain extent and thus exert its anticonvulsant properties.
Tanshinone IIA is known to play a significant role in the
TORC1−CREB pathway, controlling neuronal excitation,
proliferation of neuronal cells, and formation of long-term
memory and learning.14 The lowered c-fos expression in larval
zebrafish that were pretreated with tanshinone IIA prior to PTZ
Figure 3. Molecular structures of the tanshinones (1−4) isolated from danshen crude acetone extract.
Figure 4. PTZ-normalized concentration−response curves for (A) 15,16-dihydrotanshinone I, (B) cryptotanshinone, (C) tanshinone IIA, and (D)
miltirone. Results were normalized against PTZ controls (set at 100%). Analysis was done by two-way ANOVA, with P values <0.05 (∗), <0.01 (∗∗),
and <0.001 (∗∗∗) indicated per time period.
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exposure may be due to the regulation of TORC1−CREB
signaling, because c-fos expression is located downstream of this
pathway.14 This upstream regulation may be coupled with
tanshinone IIA’s mild affinity for GABAA receptors, which
counteracts neuronal excitation caused by glutamatergic
neurons. Tanshinone IIA has demonstrated inhibitory activity
in glutamate release from cortical synaptosomes in rats through
the suppression of presynaptic voltage-dependent Ca2+ entry
and the mitogen-activated protein kinase (MEK) signaling
cascade,26 which may also contribute to the decrease in c-fos
expression because neuronal damage due to glutamate
excitotoxicity27 may be reduced via this particular mode of
suppression.
Evaluation of Tanshinone IIA in Rodent Models. We
explored the potential activity of tanshinone IIA in two
standard rodent seizure models: the 6-Hz psychomotor seizure
assay in mice and the timed i.v. PTZ infusion test.
The 6-Hz psychomotor seizure test in rodents was reported
to be a useful model for screening anticonvulsants with novel
properties since it does not completely discriminate com-
pounds based on their mechanism of action,28 as compared
with chemoconvulsants specific to certain excitatory or
inhibitory pathways, thus making this assay an effective option
in assessing the validity of selected compounds as anti-
convulsants. Application of a 6-Hz electrical stimulus through
the corneas of mice triggers seizures that are similar to
automatisms found in human limbic epilepsy.28,29 In this assay,
doses of 0.5−1 mg/kg tanshinone IIA were successful in
protecting 5 out of 6 mice (Figure 9), thus showing potential
anticonvulsant effects by protecting the brain against limbic or
focal seizures. However, this effect was lost at higher doses of
tanshinone IIA, suggesting that the compound acts in a biphasic
or hormetic manner, since increasing or decreasing the dose of
tanshinone IIA 10-fold lowered its efficacy as an anticonvulsant
agent in the 6-Hz seizure model. Such hormetic dose responses
have indeed been previously reported in chemically diverse pro-
and anticonvulsant agents with different modes of action.30,31
Another observation is that tanshinone IIA was able to exert an
effect in the 6-Hz mouse seizure model at concentrations lower
Figure 5. PTZ-normalized concentration−response curves for intra-
venous injection of vehicle-only and tanshinone IIA in 3-dpf zebrafish
larvae that were subsequently exposed to 20 mM PTZ and tracked for
90 min. Results were normalized against PTZ controls (set at 100%).
Analysis was done by two-way ANOVA, with P values <0.05 (∗),
<0.01 (∗∗), and <0.001 (∗∗∗) indicated per time period.
Figure 6. WISH of 7-dpf zebrafish larvae to visualize the modulation
of c-fos expression: (A) larva with vehicle only pretreatment,
unexposed to PTZ before fixation and staining; (B) larva with vehicle
only pretreatment, exposed to PTZ for 30 min before fixation and
staining; (C) larva pretreated with 80 μM tanshinone IIA for 18 h,
unexposed to PTZ before fixation and staining; and (D) larva
pretreated with 80 μM tanshinone IIA before PTZ exposure, fixation,
and staining.
Figure 7. Quantitative analysis of WISH staining of 7-dpf zebrafish
larvae to visualize the modulation of c-fos expression by vehicle and 80
μM tanshinone IIA (TanIIA) with (gray bars) or without (white bars)
additional exposure to PTZ. Student’s t test was performed to
determine statistical significance with P values <0.05 (∗), <0.01 (∗∗),
and <0.001 (∗∗∗).
Figure 8. Quantitative analysis of WISH staining of i.v.-injected 3-dpf
zebrafish larvae to visualize the modulation of c-fos expression by
vehicle and 100 mM tanshinone IIA (TanIIA) with (gray bars) or
without (white bars) additional exposure to PTZ. Student’s t test was
performed to determine statistical significance with P values <0.05 (∗),
<0.01 (∗∗), and <0.001 (∗∗∗).
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than those used in preclinical cardiovascular research32 by as
much as 40-fold. This 40-fold difference can be interpreted in
the following manner: off-target or alternate system effects are
avoided, if low doses of the compound are used.
The i.v.-PTZ mouse test serves as a model for acute
generalized seizures by determining changes in seizure
thresholds. PTZ delivered via an i.v.-infusion system has
shown to be more reliable in selecting and describing
compounds with pro- or anticonvulsant effects as compared
with PTZ delivered subcutaneously, which is prone to false
positives and negatives.33 Tanshinone IIA at 10, 1, and 0.1 mg/
kg injected i.v. into mice displayed a complex response upon
continuous i.v.-PTZ infusion (Figure 10). Under these
conditions, reduction of seizure threshold was observed at the
initial stage of PTZ infusion and subsequently coupled with an
increase in threshold at latter stages (Figure 10, Table 2).
The early seizure stages triggered by the initial low-dose PTZ
correspond to generalized absence seizures,34 while the later,
tonic−clonic stages are due to the action of high-dose PTZ,
leading to generalized status epilepticus (SE) and death.35
Tanshinone IIA reduced the amount of PTZ needed to elicit
the early seizure stages (i.e., ear twitch, myoclonic twitch, tail
twitch), while it also significantly increased the amount of PTZ
needed to reach the final seizure end point (Figure 10, Table
2). The results indicate that the compound may have pro- and
anticonvulsant features, which are highly dependent on the
amount of PTZ. The failure of tanshinone IIA during the early,
low-dose PTZ stage may be due to the compound being a poor
competitor to PTZ, a GABAA antagonist, and could possibly
interact with other pathways that may exacerbate the effects of
low-dose PTZ. At higher doses of PTZ, this proconvulsant
effect is reversed; despite being a strong GABAA antagonist,
high doses of PTZ interact with non-GABA related receptors,
upon which tanshinone IIA could compete at a better
advantage. Overall, tanshinone IIA has a more complex activity
profile in this model compared with the 7-dpf larval PTZ assay.
This discrepancy may be due to numerous factors such as the
difference between mammalian and teleost brains or the
different pharmacokinetic dynamics of zebrafish and mice.7 In
the case of commercially available antiepileptic drugs, which
were tested in both zebrafish and rodent behavioral models, a
number of compounds like topiramate and zosinamide show a
positive response in zebrafish but not in rodent models.7
The disparate outcomes of both rodent models, the
ambiguity of tanshinone IIA’s activity in the i.v. PTZ assay
and its positive activity in the 6-Hz mouse seizure model,
illustrate the potentially complex mode of action of the
compound. Such disparity is not unheard of in small-molecule
screening of potential anticonvulsants; mexiletine, a class IB
antiarrhythmic drug, has anticonvulsant properties in the
maximal electroshock seizure (MES) model in mice but has
also failed in i.v. PTZ tests.36 A major concern in interpreting
results based on these animal models is that they are
administered to naıv̈e animals in an acute fashion and
consequently do not consider the pathophysiological mecha-
nisms of chronic epilepsy. However, since these models address
the question of seizure suppression, which is the primary key in
the treatment of epilepsy, the relevance of the results generated
through their use is not diminished. The National Institutes of
Health (NIH) designed a drug-screening scheme for their
anticonvulsant screening program (ASP) wherein compounds
are initially assessed for their anticonvulsant activity in at least
one acute, nonmechanistic model before subjecting them to
more discriminatory, mechanistic ones36 to determine whether
these compounds can modify the progression of the disease
aside from controlling the critical symptom (i.e., seizures).
Clearly, tanshinone IIA should be tested in additional chronic
and spontaneous seizure assays such as kindling, GAERS, and
genetic epilepsy models (among others) in order to character-
ize and validate its potential as a disease-modifying antiepileptic
compound.
To complement the rodent seizure assays for tanshinone IIA,
we wanted to determine whether the selected dose ranges could
possibly contribute to neurological effects on their own. NMRI
mice were injected i.p. with 10 and 1 mg/kg of the compound
and were subjected to the beam-walking assay. Both groups of
mice performed as well as mice injected with vehicle only,
which fared better than those injected with diazepam (1 mg/
kg), which resulted in an increase in the number of foot slips
and falls (Figure 11). Based on these results, tanshinone IIA did
not elicit sedative or similar neurological effects comparable to
diazepam, a potent GABAA agonist, despite its structural
Figure 9. Bar graphs of 6-Hz psychomotor seizure assay on male
NMRI mice treated with tanshinone IIA (44 mA; n = 6 mice per
treatment group). Analysis was done using Fischer’s exact test at 95%
confidence level to determine statistical significance (indicated by ∗).
Figure 10. Radar graphs of PTZ-i.v. infused mice treated with
tanshinone IIA (n = 6 mice per treatment group). Results for each
group were normalized against the controls (set at 100%). Mice were
scored according to the PTZ dose used per seizure progression: ear
twitch (ET), tail twitch (TT), myoclonic twitch (MT), forelimb
clonus (FC), falling (F), tonic hindlimb extension (HLE), and death
(D). Standard deviations were not included in the graph but are listed
in the corresponding table (Table 2).
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resemblance to another GABAA agonist, miltirone, thus
indicating that tanshinone IIA has a propensity to interact
with pathways other than those ascribed to GABA and related
agonists in order to exert its anticonvulsant properties.
In conclusion, we have demonstrated that the acetone crude
extract of danshen can significantly reduce convulsions induced
in our larval zebrafish-PTZ assay and that a number of its
hydrophobic tanshinones are responsible for this activity. One
such tanshinone, tanshinone IIA, is active in both the zebrafish-
PTZ and mouse 6-Hz psychomotor seizure models and has a
complex profile in the mouse-PTZ infusion model. The issues
regarding its solubility, bioavailability, and multitarget effects
could possibly be addressed by exploring more water-soluble
derivatives, some of which have readily available pharmacoki-
netic data,13,15 making tanshinones a potential source of novel
anticonvulsants.
! METHODS
Plant Materials and Reagents. Dried danshen root powder was
purchased from Tong Ren Tang, Beijing (http://www.tongrentang.
com/en/index.php). Tanshinone IIA and dihydrotanshinone I stand-
ards (98% purity via HPLC) were sourced from IMAM International
Pharmaceuticals, Ltd. (Tianjin, China).
Crude Extract Preparation. Five grams of dried danshen root
powder was dispersed in 50 mL of acetone via ultrasonication
(Bransonic 5510E-MT: Danbury 06813, USA); the resulting solution
was filtered and reduced to dryness (60 mg). The resulting residue
(CE) was dissolved in spectroscopic-grade dimethyl sulfoxide
(DMSO; Acros Organics, Geel, Belgium) as 20 mg/mL stock solution.
For rodent assays, the residue was dissolved in 50/50 DMSO/
poly(ethylene glycol)-200 (DMSO/PEG-200) as a 100 mg/mL stock
solution. All stock solutions were stored at −20 °C.
High-Performance Liquid Chromatography (HPLC). Approx-
imately 200 μg of the crude extract was dissolved in 20 μL of HPLC-
grade acetonitrile (ACN; Acros Organics, Geel, Belgium) and was
injected into a Hitachi EZChrom Elite HPLC system with a Luna C-
18(2) reversed-phase silica analytical column (Phenomenex, Torrance,
CA, USA), a quaternary solvent pump, and a diode array detector. A
gradient solvent system (0−40 min, 50% ACN/water to 100% ACN;
41−60 min, 100% ACN to 50% ACN/water) at 0.8 mL/min was used
to resolve the components in the extract. For semipreparative work, 10
mg of the extract was injected in a Gilson 712 HPLC system with a
Waters 2487 dual-wavelength detector (Waters USA, Milford, MA,
USA) and Sun Fire Prep C-18 reversed-phase semipreparative column
(10 ! 250 mm2, 5 μm; Waters USA, Milford, MA, USA). A similar
gradient solvent system at 2.5 mL/min was used in this scheme to
isolate fractions of the components. The isolated fractions were subject
to rotary evaporation and purged with dry N2 gas to obtain residues
for further analyses.
Nuclear Magnetic Resonance Spectroscopy (NMR). The
residues were dissolved in 2.5 mL of deuterated DMSO (Sigma-
Aldrich, St. Louis, MO, USA) in 5-mm inner diameter glass NMR
tubes and run in a Bruker Avance 600-MHz NMR spectrometer. Data
and structure analyses for proton and carbon signals used ACDLabs
NMR Processor Academic Edition 12 (ACDLabs, Cambridge, MA,
USA).
Zebrafish. Adult zebrafish (AB strain) were reared at 28 °C on a
14/10 h light/dark cycle according to standard aquaculture conditions.
Eggs were collected following natural spawning, sorted, and raised in
0.3! Danieau’s solution (1.5 mM HEPES, pH 7.6, 17.4 mM NaCl,
Table 2. Mean PTZ Dose Corresponding to Specific Seizure Phenotype Per Treatment Group Correlated to the Radar Graph in
Figure 9a
mean PTZ dose corresponding to specific seizure phenotype (mg/kg)
control (vehicle only) 0.1 mg/kg TanIIA 1 mg/kg TanIIA 10 mg/kg TanIIA
ear twitch (ET) 77.1 ± 7.5 44.7 ± 5.4* 42.4 ± 2.0* 45.1 ± 1.5*
myoclonic twitch (MT) 83.0 ± 2.9 51.6 ± 8.9* 58.0 ± 6.5* 54.1 ± 5.9*
tail twitch (TT) 86.2 ± 3.8 55.4 ± 10.8* 58.0 ± 6.5* 60.7 ± 4.5*
forelimb clonus (FC) 103.3 ± 20.3 62.0 ± 18.4* 74.8 ± 10.0 73.2 ± 7.6
falling (FL) 101.8 ± 21.8 66.9 ± 21.6* 74.3 ± 16.3 81.8 ± 16.4
tonic hindlimb extension (HLE) 125.6 ± 13.6 163.3 ± 35.2* 132.0 ± 29.0 128.1 ± 10.8
death (D) 134.2 ± 12.5 189.6 ± 36.9* 161.7 ± 22.4* 153.3 ± 8.9*
aStatistical analysis was done using one-way ANOVA with Dunnett’s test, with significant differences (indicated by *, P < 0.001) seen for all
tanshinone IIA treatment sets.
Figure 11. Scores for beam-walking assay of male NMRI mice treated with 1 and 10 mg/kg tanshinone IIA (n = 6 mice per treatment group).
Statistical analysis was done using one-way ANOVA with Dunnett’s test, with P values <0.05 (∗), <0.01 (∗∗), and <0.001 (∗∗∗) indicated per
treatment group.
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0.21 mM KCl, 0.12 mM MgSO4, and 0.18 mM Ca(NO3)2) under
constant light conditions in an incubator set at 28 °C until 7 dpf.
Mice. Male 10−12-week-old C57Bl/6 and NMRI mice were kept
on a 12/12 h light/dark cycle and were provided with standard rodent
diet ad libitum. All aspects of animal experiments and husbandry were
carried out in strict compliance with the National and European
Regulations and were approved by the Animal Care and Use
Committee of KU Leuven (Ethische Commissie van de KU Leuven,
approval numbers P101/2010 and P061/2013) and in accordance
with Belgian and European Laws, guidelines, and policies for animal
experimentation, housing, and care (Belgian Royal Decree of April 6,
2010, and European Directive 2010/63/EU on the protection of
animals used for scientific purposes).
Automated Larval Zebrafish PTZ Assay. One 7-dpf zebrafish
larva was placed in each well of a 96-well plate. Excess larval medium
was removed and replaced with 100 μL of either control or sample
solution. The prepared plate was placed in a dark box inside an
incubator, set at 28 °C, for 1 or 18 h, and each well was subsequently
inspected for signs of toxicity (e.g., irregular heart-rate, loss of posture,
edema, necrosis, delayed startle or touch response). The maximum
tolerated concentration (MTC) was designated as the highest sample
concentration that did not elicit any signs of toxicity in 6/7-dpf larvae
after 18 h of exposure.7 Upon addition of 100 μL of 40 mM PTZ per
well, the plate was positioned in the zebrafish tracking box (Viewpoint,
Lyon, France), and the larvae were allowed to habituate for 5 min
before recording for 30 min. Tracking data was exported into Excel
format and processed as such before statistical analysis via GraphPad
Prism v.5 for Windows. Each tracking data set was normalized against
the PTZ-only control values (set at 100%) within each set, with each
subsequent replicate set pooled before two-way ANOVA with
Bonferroni post hoc analysis.
Intravenous Microinjection of Tanshinone IIA into 3-dpf
Zebrafish Larvae. In order to overcome potential issues with
tanshinone IIA’s solubility in the larval medium, i.v. microinjections
were performed. Three days post-fertilization zebrafish larvae were
anesthetisized with tricaine before securing them on a grooved agarose
mold in supine position. One-half nanoliter of tanshinone IIA (100
mM in 50% DMSO) was injected into the circulation through the duct
of Cuvier (future common cardinal vein, CCV) 37 using a pulled-glass
capillary needle. Injected larvae were left to recover in tricaine-free
larval medium in 96-well plates for 30 min before exposure to 20 mM
PTZ for automated locomotor assays, with corresponding sets of
sham-injected and uninjected larvae for controls.
Whole Mount in Situ Hybridization (WISH) of 7-dpf
Zebrafish Larvae for Brain c-fos Expression. This assay was
performed to assess the extent of seizure suppression in zebrafish
brains, because increased c-fos expression serves as a well-documented
indicator for seizure onset in both fish and mammalian models.6,25 At
least 30 6/7-dpf larvae were exposed to 1 mL of vehicle or sample
solution 18 h before addition of 1 mL of 40 mM PTZ for 30 min. The
treated larvae were fixed in 4% paraformaldehyde overnight and then
exposed to 10 μg/mL proteinase K before hybridization with a
digoxigenin-labeled c-fos RNA probe, according to standard
procedures.6,25,38 The extent of staining was quantified using KS300
software (Carl Zeiss, Bulgaria) and analyzed via unpaired Student’s t
test with GraphPad Prism v.5 for Windows.
Timed PTZ-Infusion Mouse Assay. Twenty-four C57Bl/6J mice
were divided into control and treatment groups of six mice each. Mice
were restrained, and a lateral caudal vein was catheterized with a 1-cm
29-gauge needle attached to polyethylene tubing, secured with surgical
tape. One-hundred microliters of vehicle (50/50 DMSO/PEG200) or
different concentrations of tanshinone IIA was i.v.-infused into mice
for 2 min at 50 μL/min using an automated i.v. injector pump (World
Precision Instruments ALADOIN-1000 11VDC, 0.75 Å) and then
incubated for 10 min before shifting to a continuous infusion of 7.5
mg/mL PTZ (0.9% saline water) at 150 μL/min. Mice were scored
according to the time latencies of seizure progression: ear twitch (ET),
tail twitch (TT), myoclonic twitch (MT), forelimb clonus (FC), falling
(F), tonic hindlimb extension (HLE), and death (D). All surviving
mice were euthanized immediately at the end of the infusion.
6-Hz Psychomotor Seizure Assay in Mice. NMRI mice of
approximately 30−35 g were grouped six per cage. Each mouse was
injected i.p. with vehicle (50/50 DMSO/PEG200) or different
concentrations of danshen crude extract or tanshinone IIA 30 min
before the procedure. Seizures were induced via corneal stimulation
(6-Hz, 0.2-ms rectangular pulse width) using a Ugo-Basil device. Prior
to the placement of corneal electrodes, a drop of 0.5% xylocaine was
applied to the eyes of the animal. Animals were restrained manually
and released immediately in a cage of Plexiglas following the
stimulation. Then the animal was observed for characteristic signs
such as stun, forelimb clonus, twitching of vibrissae, and Straub tail for
at least 45 s. Protection was defined as the absence of a seizure within
the expected time frame.
Beam-Walking Test. NMRI mice of approximately 30−35 g were
grouped six per cage and were trained three times to walk across an
80-cm wooden beam from an open platform. Each mouse was injected
i.p. with vehicle (50/50 DMSO/PEG200), tanshinone IIA (10 and 1
mg/kg), or diazepam (1 mg/kg) 30 min before the actual experiment.
The duration of the crossings, number of foot slips and falls were
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